安心交易
不成功退款，无后顾之忧，风险服务升级。
Amyloid: the Journal of Protein Folding Disorders is dedicated to the study of all aspects of the protein groups and associated disorders that are classified as the amyloidoses as well as other disorders associated with abnormal protein folding. The Journal has a major focus on etiology, pathogenesis, histopathology, chemical structure and the nature of fibrillogenesis and also publishes papers on the genetic aspects (both basic and clinical) of many of these disorders. Amyloid is recognised as one of the leaders in the publication of the classification of the amyloid proteins and the associated disorders as well as clinical studies of all aspects of the amyloid related neurodegenerative diseases and major clinical studies on the inherited amyloidosis, especially those related to transthyretin. The Journal also publishes Book Reviews, Meeting Reports, Editorials, Thesis Abstracts, Review Articles and Symposia in the various areas listed above. It has been recommended to basic scientists, students of the neurodegenerative disorders (neurologists), histopathologists, geneticists and to a broad spectrum of clinicians, whose specialties are impacted by various amyloid diseases. Amyloid: the Journal of Protein Folding Disorders is the official journal of the International Society of Amyloidosis.
淀粉样蛋白:《蛋白质折叠障碍杂志》致力于研究蛋白质组和相关疾病的所有方面，这些疾病被归类为淀粉样蛋白病以及其他与蛋白质折叠异常相关的疾病。该杂志主要关注病因学、发病机制、组织病理学、化学结构和纤维形成的本质，并发表了许多关于这些疾病的遗传方面(基础和临床)的论文。淀粉样蛋白被认为是淀粉样蛋白和相关疾病分类、淀粉样蛋白相关神经退行性疾病各方面的临床研究以及遗传淀粉样变性的主要临床研究的领导者之一，特别是与转甲状腺素相关的研究。该杂志还出版上述各个领域的书评、会议报告、社论、论文摘要、评论文章和座谈会。它已被推荐给基础科学家，神经退行性疾病的学生(神经病学家)，组织病理学家，遗传学家和广泛的临床医生，其专业受到各种淀粉样蛋白疾病的影响。淀粉样蛋白:《蛋白质折叠障碍杂志》是国际淀粉样变性协会的官方杂志。
安心交易
不成功退款，无后顾之忧，风险服务升级。
合规备案认证机构
资质许可齐全，合规经营，用户权益有保障。
正刊保障
刊物在国家新闻出版署网可查，抵制假刊、增刊。
对公账户资金监管
交易均通过对公账户，资金安全有保障。01 选择服务并上传稿件 我们的学术顾问将根据您的需求推荐适合的服务
02 分配资深编辑和同行专家 根据您的服务方案和研究方向，为您分配资深编辑和同行专家
03 交付及反馈 每个环节的服务会在您审阅和确认后进行下一步，根据您的反馈和建议做调整
04 提升稿件质量 我们将基于您的反馈并平衡期刊的投稿要求，为您进一步优化稿件
05 提交投稿 出版专家将在您确认定稿后，为您整理并检查所有必须文件，协助您完成期刊投稿。
06 投稿跟进 及时查询稿件状态，协助您与期刊编辑沟通，根据审稿意见协助修正文章
07 拒稿支持 若期刊拒稿，您可通过拒稿咨询服务发掘稿件的改进方案，并获取365天无限次向同期刊或其他期刊的重投服务
